LDN-27219 is a highly effective small molecule inhibitor of human tissue transglutaminase (hTGase), exhibiting an IC50 value of 0.6 µM. This compound is a valuable research tool for investigating the role of transglutaminase activity in various disease models, including celiac disease and fibrosis, in both cellular and biochemical studies.